PFE - Pfizer Inc.

NYSE - Nasdaq Real-time price. Currency in USD

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sector(s)Healthcare
IndustryDrug Manufacturers—General
Full-time employees83,000

Key executives

NameTitlePayExercisedYear born
Dr. Albert Bourla D.V.M., DVM, Ph.D.Chairman & CEO11.72MN/A1962
Mr. Frank A. D'AmelioCFO & Exec. VPN/AN/A1958
Mr. David M. DentonChief Financial Officer & Exec. VP18.19MN/A1965
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical5.82MN/A1958
Ms. Angela HwangChief Commercial Officer & Pres of Global Biopharmaceuticals Bus.4.89M7.7M1966
Dr. William Pao M.D., Ph.D.Exec. VP & Chief Devel. Officer11.26MN/A1967
Ms. Jennifer B. DamicoSr. VP, Controller & Principal Accounting OfficerN/AN/A1968
Ms. Lidia L. FonsecaExec. VP and Chief Digital & Technology OfficerN/AN/A1969
Mr. Christopher J. Stevo CFASr. VP & Chief Investor Relations OfficerN/AN/AN/A
Mr. Douglas M. LanklerExec. VP & Gen. CounselN/AN/A1966
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate governance

Pfizer Inc.’s ISS governance QualityScore as of 30 May 2023 is 3. The pillar scores are Audit: 10; Board: 6; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.